LENZ Therapeutics, Inc. (NASDAQ: LENZ) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT LENZ THERAPEUTICS, INC.

LENZ Therapeutics, Inc. (NASDAQ: LENZ)
Listen to this Section


$26.33
+0.3500 ( +0.77% ) 11.6K

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Market Data


Open $26.33
Previous Close $25.98
Volume 11.6K
Market Cap $719.15M
Day Range $25.65 - $26.98
52 Week Range $14.42 - $38.93
Shares Outstanding 27.50M
Change % +0.77%
Net Change ▲ 0.3500
Insider Ownership -0.03%
Exchange NASDAQ
Sector Miscellaneous
Industry None
IPO Year 2024
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 2,375,821.00

Date Type Amount Purchased Purchaser
2024-07-23 Sale -45000.00 Schimmelpennink Evert B.
2024-05-15 Buy 3188.00 Chevallard Daniel R.
2024-05-14 Buy 31332.00 MCCOLLUM JAMES W
2024-03-25 Buy 2386301.00 RA CAPITAL MANAGEMENT, L.P.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 15, 2024
4 Insider transactions 1 May 14, 2024
10-q Quarterly Reports 61 May 08, 2024
8-k 8K-related 15 May 08, 2024
8-k 8K-related 28 Apr 03, 2024
3 Insider transactions 1 Mar 28, 2024
4 Insider transactions 1 Mar 25, 2024

Latest News


× Before browsing our site, please accept our cookies policy